Men in Australia Telephone Survey (MATeS): a National Survey of the Reproductive Health and Concerns of Middle-aged and Older Australian Men
Overview
Authors
Affiliations
Background: The Men in Australia Telephone Survey (MATeS) describes the prevalence of self-reported reproductive health disorders as well as related concerns and health behaviours among middle-aged and older Australian men.
Methods: A representative sample population (n=5990) of Australian men (>or=40 years) was obtained by contacting a random selection of households with unbiased sampling, stratified by age and state. A 20-min computer-assisted telephone interview was done to assess reproductive health and related knowledge and beliefs, sociodemographic factors, general health, and lifestyle factors.
Findings: A response rate of 78% (5990/7636) was achieved. 34% (1627/4737) of men surveyed reported one or more reproductive health disorder, all of which were most common in the oldest age group. Age-standardised prevalence of significant lower urinary tract symptoms was 16%, erectile dysfunction was 21%, and prostate disease was 14%. About 50% of participants reported having had a prostate cancer test whereas only 30% (300/1012) of men with erectile dysfunction sought medical help. Willingness to seek medical help for erectile dysfunction was related to age and ethnic origin. Although men aged 40-69 years expressed a moderate or high level of concern about prostate cancer and loss of erectile function, concern about reproductive health was less in the oldest age group (>or=70 years).
Interpretation: The high prevalence of reproductive health disorders and associated concerns in middle-aged and older Australian men draws attention to the need to develop appropriate services and education strategies specifically directed to improving reproductive health in these men.
Zhang Y, Zang N, Xiang Y, Lin F, Liu X, Zhang J Front Endocrinol (Lausanne). 2025; 15:1412369.
PMID: 39872316 PMC: 11769807. DOI: 10.3389/fendo.2024.1412369.
Tran M, van Zwieten A, Kiely K, Blyth F, Naganathan V, Le Couteur D SSM Popul Health. 2024; 25:101581.
PMID: 38264197 PMC: 10803938. DOI: 10.1016/j.ssmph.2023.101581.
Wizgier D, Meng Y, Das A, Naganathan V, Blyth F, Le Couteur D Br J Nutr. 2024; 131(9):1528-1539.
PMID: 38220224 PMC: 11043910. DOI: 10.1017/S0007114524000126.
Stigmatization as a Barrier to Urologic Care: A Review.
Foster P, Luebke M, Razzak A, Anderson D, Hasoon J, Viswanath O Health Psychol Res. 2023; 11:84273.
PMID: 37670795 PMC: 10477007. DOI: 10.52965/001c.84273.
ATP5D Is a Potential Biomarker for Male Fertility.
Wang Y, Zhai C, Yao G, Chen T, Xue L, Zhou L Oxid Med Cell Longev. 2023; 2023:4923614.
PMID: 36686378 PMC: 9848815. DOI: 10.1155/2023/4923614.